Abstract:BackgroundEstrogen receptor (ER) expression is important for treatment selection and prognostication of breast cancer patients. Although the metastases are the main targets of endocrine therapy, ER status is often based on the primary tumor. However, ER expression in breast cancer primary lesion may not match with its synchronous metastatic lesions in some cases. In this study, we analyzed ER expression concordance between breast cancer primary tumor and metastatic lesions.MethodsParaffin blocks of 100 primary breast invasive ductal carcinoma cases with axillary lymph node metastases were collected. Five tissue cores were punched out from individual primary breast cancer, and one tissue core from each lymph node metastases to assemble tissue microarrays for ER staining. Samples were then scored as 0, 1+, 2+, and 3+ according to the number and intensity of ER stained tumor cells.ResultsFor cases with ER 3+ (strong expression) in all cores of primary lesions (n=38), ER expression in metastatic lymph node was found in 94.7% of the patients. 91.0% of the metastatic lymph nodes were ER positive, and 84.3% of them to be 3+. Among the 46 cases of ER negative expression in all cores of primary lesions, 39 of them had all the metastatic nodes being ER negative, and ER negative nodes were seen in 95.7% of the metastases. As for 16 cases of ER inconsistent expression in primary lesions, 4 cases showed negative ER expression in all metastatic nodes, 2 cases displayed diffuse consistent ER 3+ expression, and 10 cases displayed variant ER expression.ConclusionsThe findings suggest that ER expression concordance between breast cancer primary lesion and its matched metastatic lesions could be estimated by primary tumor ER expression pattern.

Correlation between expression of c-erbB2 and the micrometastases in peripheral blood in breast cancer

The Expression and Clinical Significance of PCNA and C-erbB-2 in Breast Cancer Tissue

Expression of C-erbB-2 and nm23 proteins in breast cancer and their clinical signifi cance

Detection of SBEM-mRNA level in peripheral blood of patients with breast cancer and its clinical significance

Detection of SBEM-mRNA in Peripheral Blood of Patients with Breast Cancer and Its Clinical Significance

Relationship Between Images of Color Doppler Ultrasonography and C-Erbb-2 Expression in Patients with Breast Cancer

Expression of C-erbB-2 Protein in Different Sliding Techniques of Breast Cancer

Study of Differential Polymerase Chain Reaction of C-erbB-2 Oncogene Amplification in Gastric Cancer

Expression of ER,PR, C-erbB-2 and Ki-67 Genes in Breast Cancer and Their Clinical Significance

[Expression of Small Breast Epithelial Mucin Mrna in Peripheral Blood of Breast Cancer Patients and Its Clinical Significance].

Expression and Clinical Significance of C-erbB-2 in Colorectal Carcinoma

A study of c-erbB2 amplification in breast cancer by differential polymerase chain reaction

Breast Cancer Primary Tumor ER Expression Pattern Predicts Its Expression Concordance in Matched Synchronous Lymph Node Metastases

Molecular Biological Markers Expression in Breast Cancer and Its Relationship with Clinicopathological Features

Correlation Analysis between Expression Profiles of Molecular Markers and Contrast-Enhanced Ultrasound Parameters in Breast Cancer

Relation between axillary node metastasis and the expression of c-erbB-2 and p53 in breast cancer

Expressions of Progesterone Receptor a and B in Breast Invasive Ductal Carcinoma and Their Clinical Significance

Study of CCL28 expression in breast cancer

Relationship between expression of MMP-2 and cervical lymph node micrometastasis in oral squamous cell carcinoma

Relationship Between the Expression of C-Erbb-2,nm-23,er,pr and Five-Year Tumour-Free Survival Time in Primary Breast Cancer

Study on the expression of HER2 and BCRP in human breast cancer and correlated analysis